Search results for " Local"

showing 10 items of 2101 documents

Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study

2005

Abstract BACKGROUND/AIMS: To assess the effectiveness and the safety of radio-frequency thermal ablation (RFTA) in patients with hepatocellular carcinoma (HCC) or = 35 g/L, platelet count > or = 100.000/mmc, tumor size < or = 3 cm, complete response at 1 month and Barcelona Clinic Liver Cancer (BCLC) staging classification. Overall recurrence rates were 22, 38, and 44% at 12, 24, and 30 months, respectively. One procedure-related death occurred. The proportion of major complications after treatment was 3.9%. CONCLUSIONS: A complete response after RFTA significantly increases survival. The longest survival is obtained in the presence of HCC < or = 3 cm and of higher baseline albumin levels a…

Liver CirrhosisMalemedicine.medical_specialtyCarcinoma HepatocellularCirrhosisGastroenterologyCohort StudiesInternal medicineHumansMedicineProspective StudiesProspective cohort studySurvival analysisAgedLaparotomyHepatologybusiness.industryProportional hazards modelLiver NeoplasmsMiddle AgedPrognosismedicine.diseaseSurvival AnalysisSurgeryHepatocellular carcinoma Radio frequency thermal ablation CirrhosisHepatocellular carcinomaCohortCatheter AblationFemaleNeoplasm Recurrence LocalbusinessLiver cancerFollow-Up StudiesCohort study
researchProduct

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicen…

2017

SummaryBackground Data on HCV-related hepatocellular carcinoma (HCC) early recurrence in patients whose HCC was previously cured, and subsequently treated by direct-acting antivirals (DAAs), are equivocal. Aim To assess the risk of HCC early recurrence after DAAs exposure in a large prospective cohort of HCV-cirrhotic patients with previous successfully treated HCC, also looking for risk factors for cancer early recurrence. Methods We enrolled 143 consecutive patients with complete response after curative treatment of HCC, subsequently treated with DAAs and monitored by the web-based RESIST-HCV database. Clinical, biological, and virological data were collected. The primary endpoint was the…

Liver CirrhosisMalemedicine.medical_specialtyCarcinoma HepatocellularSettore MED/09 - Medicina InternaEarly RecurrenceDIRECT ACTING ANTIVIRALSAntiviral AgentsGastroenterologyhepatocellular carcinoma (HCC)03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineClinical endpointCarcinomaHumansPharmacology (medical)Prospective StudiesProspective cohort studyneoplasmsComplete responseAgedhepatocellular carcinoma (HCC) HCV directacting antivirals (DAAs)Settore MED/12 - GastroenterologiaSettore MED/08 - ANATOMIA PATOLOGICAHepatologybusiness.industrydirectacting antivirals (DAAs)Liver NeoplasmsCarcinomaGastroenterologyCancerHepatocellularMiddle Agedmedicine.diseaseHepatitis Cdigestive system diseasesNeoplasm RecurrenceLocal030220 oncology & carcinogenesisHepatocellular carcinomaHCVCatheter AblationFemale030211 gastroenterology & hepatologyNeoplasm Recurrence Localbusiness
researchProduct

A human renal cancer line as a new antigen source for the detection of antibodies to cytoplasmic and nuclear antigens in sera of patients with Wegene…

1991

Autoantibodies directed against cytoplasmic antigens of neutrophils (ANCA), especially proteinase 3 (C-ANCA), have proved to be a useful clinical tool to support the diagnosis or to monitor disease activity in Wegener's granulomatosis (WG). Till now, human neutrophil granulocytes have represented the major antigen source used to detect antibodies in WG by the immunofluorescence technique (IFT). We have tested serum samples of 164 patients with different connective tissue diseases (50 suffering from clinically active WG) performing IFT on a human renal cancer line (SK-RC11) and have found antibodies against the nuclear and cytoplasmic antigens in 39 patients. C-ANCA+ sera displayed a charact…

Liver CirrhosisTime Factorsmedicine.drug_classNeutrophilsImmunologyBlotting WesternFluorescent Antibody TechniqueImmunofluorescenceMonoclonal antibodyAutoantigensMonocytesSerologyCell LineArthritis RheumatoidScleroderma LocalizedAntigenProteinase 3medicineImmunology and AllergyHumansLupus Erythematosus SystemicAnti-neutrophil cytoplasmic antibodyAutoantibodiesMixed Connective Tissue Diseasemedicine.diagnostic_testbiologyTumor Necrosis Factor-alphaGranulomatosis with PolyangiitisBiological Transportmedicine.diseaseVirologyMolecular biologyKidney NeoplasmsSjogren's SyndromeAntibodies Antinuclearbiology.proteinInterferonsAntibodyGranulomatosis with polyangiitisGranulocytesJournal of immunological methods
researchProduct

Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?

2018

Direct acting antivirals stabilize or improve liver function in the majority of patients with hepatitis C virus cirrhosis. Hepatic decompensation is the main driver of death of patients with early, successfully treated hepatocellular carcinoma superimposed to cirrhosis. Treatment with direct acting antivirals could improve the prognosis of these subjects, independently from the subsequent course of hepatocellular carcinoma, if the efficacy in obtaining viral clearance is as high as in patients without a history of hepatocellular carcinoma, and if the risk of hepatocellular carcinoma recurrence is unaffected. When dealing with hepatocellular carcinoma patients, direct acting antivirals can b…

Liver Cirrhosismedicine.medical_specialtyCirrhosisCarcinoma Hepatocellularmedicine.medical_treatmentHepacivirusLiver transplantationGastroenterologyAntiviral Agents03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansHCCHepatologybusiness.industryLiver NeoplasmsCancerHepatitis CHepatitis C Chronicmedicine.diseasedigestive system diseasesLiver Transplantation030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyLiver functionNeoplasm Recurrence LocalViral hepatitisbusinessLiver cancerLiver international : official journal of the International Association for the Study of the Liver
researchProduct

La mesura de l'ús de les llengües en els mitjans telemàtics

2020

La consolidació de l'entorn digital i totes les seues modalitats de comunicació ha ampliat les possibilitats d'interacció i, per tant, els àmbits d'ús de les llengües. Com a adaptació a aquesta nova realitat, en aquesta aproximació metodològica plantegem la combinació de diferents tècniques no reactives: explotació de fonts secundàries, observació sistemàtica, i mystery shopping. Les fonts d'observació directa ens permeten mesurar de manera efectiva l'ús de les llengües en la comunicació telemàtica. Els autors ho han aplicat específicament en l'administració local i en empreses de serveis. En l'àmbit administratiu, a més, això ens ha servit per a desenvolupar un índex global de presència de…

LluísEmpreses de ServeisAdministració LocalPenalva-Verdúen aquesta aproximació metodològica plantegem la combinació de diferents tècniques no reactives: explotació de fonts secundàriesXarxes socialsaixò ens ha servit per a desenvolupar un índex global de presència del valencià en els mitjans telemàtics. L?aplicació de l?índex revetla que els ajuntaments no sobrepassen el 60% de mitjans en valenciàUsos Lingüísticsper tanti mystery shopping. Les fonts d?observació directa ens permeten mesurar de manera efectiva l?ús de les llengües en la comunicació telemàtica. Els autors ho han aplicat específicament en l?administració local i en empreses de serveis. En l?àmbit administratiuUNESCO::SOCIOLOGÍAUsos lingüísticsservice companies1137-7038 8537 Arxius de sociologia 562372 2020 42 7674044 La mesura de l?ús de les llengües en els mitjans telemàtics Català Oltralanguage usesInternetlocal administrationClemente La consolidació de l?entorn digital i totes les seues modalitats de comunicació ha ampliat les possibilitats d?interacció iobservació sistemàtica:SOCIOLOGÍA [UNESCO]Administració localexplotació de fonts secundàries [en aquesta aproximació metodològica plantegem la combinació de diferents tècniques no reactives]Valencianfet que demostra que encara estan lluny de la normalitat lingüística. Valenciàels àmbits d?ús de les llengües. Com a adaptació a aquesta nova realitatXarxes SocialsValenciàa mésEmpreses de serveissocial networks 223 233Sociología
researchProduct

A comparative statistical analysis between the italian local banks, the effects of the financial crisis on funding and credit policies

2014

This work intends to carry out a comparative statistics between Italian banks (both co-operative banks that banks) about their economic and corporate profiles in the period immediately before (2006-2007) and in the immediate aftermath (2008- 2011) to the international financial crisis. In this way, we will try to investigate whether the global economic shock caused any differences between these banks in their funding policies, credit policies.

Local BanksFinancial CrisisFinancial Crisis Local Banks Banking StrategyBanking Strategy
researchProduct

Agencias de empleo y desarrollo local: ¿una actividad del Tercer Sector?

2010

Ricardo.Calvo@uv.es En la actualidad, el desarrollo económico y social de un territorio necesita de los esfuerzos mancomunados de todos y cada uno de los agentes presentes en el medio. Es por ello que el presente artículo pretende reflexionar sobre la vinculación directa existente entre dos de ellos, por un lado las Agencias de Desarrollo Local –ADL’scomo máximo exponente del modelo de desarrollo local y por otro las organizaciones pertenecientes al Tercer Sector, como entidades clave en el sostenimiento y desarrollo social de la comunidad. Para ello partiendo de las características propias del modelo actual de desarrollo local implantado, propondremos dos decálogos de conclusiones, que ana…

Local Development ; Local Development Agents ; ADL ; AEDL ; Third SectorLocal DevelopmentADLAEDLdesarrollo localDesarrollo local ; Agentes de Desarrollo Local ; ADL ; AEDL ; Tercer SectorDesarrollo localLocal Development AgentsTercer SectorUNESCO::CIENCIAS ECONÓMICAS::Organización y dirección de empresaslcsh:Social Scienceslcsh:HThird Sectortercer sectorAgentes de Desarrollo Locallcsh:H1-99lcsh:Social sciences (General):CIENCIAS ECONÓMICAS::Organización y dirección de empresas [UNESCO]Aposta
researchProduct

Volume and effectiveness assessment of articain 4% versus mepivacaine 2% used in third molar surgery : randomized, double-blind, split-mouth controll…

2020

Made available in DSpace on 2021-06-25T11:06:11Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-01-01 Background: The different indications for extraction of the lower third molars, require resources to manage pain and discomfort, such as, for example, adequate anesthetic techniques, and the type of anesthetic used can in-fluence the management of pain in tooth extractions. Few studies in the literature compare the anesthetics 4% articaine hydrochloride and 2% mepivacaine hydrochloride showing evidence that both allow for successful pain management. This study sought to compare the volume, efficacy and safety of these two anesthetic drugs, both associated with epinephrine at a ratio …

Local anaesthesiaVisual analogue scaleAnesthesia DentalMepivacainePainCarticaineArticaineArticaine Hydrochloridelaw.inventionCarticaineRandomized controlled trialDouble-Blind MethodlawThird molarmedicineHumansParesthesiaAnesthetics LocalGeneral Dentistrybusiness.industryResearch:CIENCIAS MÉDICAS [UNESCO]Clinical trialOtorhinolaryngologyAnesthesiaAnestheticMepivacaineTooth ExtractionUNESCO::CIENCIAS MÉDICASSurgeryMolar ThirdOral Surgerybusinessmedicine.drug
researchProduct

Bupivacaine 0.5% versus articaine 4% for the removal of lower third molars. A crossover randomized controlled trial.

2012

Objective: To compare the anesthetic action of 0.5% bupivacaine in relation to 4% articaine, both with 1:200,000 epinephrine, in the surgical removal of lower third molars. As a secondary objective hemodynamic changes using both anesthetics were analyzed. Study Design: Triple-blind crossover randomized clinical trial. Eighteen patients underwent bilateral removal of impacted lower third molars using 0.5% bupivacaine or 4% articaine in two different appointments. Preoperative, intraoperative and postoperative variables were recorded. Differences were assessed with McNemar tests and repeated measures ANOVA tests. Results: Both solutions exhibited similar latency times and intraoperative effic…

Local anesthesiaAdultMalemedicine.medical_specialtyAnestèsia en odontologiaAdolescentHemodynamicsCarticaineArticainelaw.inventionPostoperative painYoung AdultDolor postoperatoriClinical trialsRandomized controlled trialDouble-Blind MethodlawMedicineTeeth extractionHumansAnesthetics LocalGeneral DentistryExtracció dentalBupivacaineCross-Over Studiesbusiness.industryRepeated measures designAnestèsia localDent molar:CIENCIAS MÉDICAS [UNESCO]Crossover studyMolarBupivacaineSurgeryBlood pressureOtorhinolaryngologyAnesthesiaAnestheticUNESCO::CIENCIAS MÉDICASTooth ExtractionSurgeryFemaleMolar ThirdResearch-ArticleAnesthesia in dentistryOral Surgerybusinessmedicine.drugAssaigs clínicsMedicina oral, patologia oral y cirugia bucal
researchProduct

Anesthetic efficacy of Oraqix versus Hurricaine and placebo for pain control during non-surgical periodontal treatment

2014

Objectives: To evaluate the efficacy of Oraqix® during scaling and root planing (SRP) in comparison with 20% benzocaine and placebo. Study Design: 15 patients requiring 4 sessions of SRP were enrolled. For each patient, Oraqix®, Hurricaine®, vaseline or no anesthetic product were randomly assigned each to a quadrant. Treatment pain was evaluated on a 100 mm Visual Analog Scale (VAS) and on a Verbal Rating Scale (VRS). The amount of product administered, the need to re-anesthetise, patient and operator satisfaction and the onset of side-effects were also recorded. Results: Oraqix® was significantly better than nothing, with a reduction of VAS score to 13.3 units, but without significant diff…

Local anesthesiaMaleLidocaineBenzocaineRoot PlaningClinical trialsScaling and root planingPain treatmentAnesthesiaPeriodontologyAnesthetics LocalAnestèsia localMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludBenzocaineTreatment OutcomeAnesthesiaUNESCO::CIENCIAS MÉDICASFemaleAnesthesia in dentistryPeriodontal diseasemedicine.drugAdultAnestèsia en odontologiamedicine.medical_specialtyVisual analogue scaleOdontologíaMalalties periodontalsPlaceboPrilocaineVaselineTractament del dolorDouble-Blind MethodmedicineHumansPain ManagementLidocaine Prilocaine Drug CombinationGeneral DentistryAgedbusiness.industryResearchLidocainePrilocaineSurgeryOtorhinolaryngologyAnestheticDental ScalingSurgerybusinessAssaigs clínicsMedicina Oral Patología Oral y Cirugia Bucal
researchProduct